《沪深两市》上证半日倒跌0.4% 深成创板跌1.1%-1.5% 半导体、光伏股下滑
人行今开展800亿元人民币(下同)逆回购操作，单日净投放800亿元。人民币兑美元中间价报6.6781，上调149点。上证深成今早微微高开後缺乏承接转跌。
上证半日跌11点或0.4%，收报3,316点；深成跌153点或1.1%，收报13,450点；沪深300指数跌15点或0.3%，收报4,777点；创业板指数跌40点或1.5%，收报2,699点，成交1,697亿元。沪深两市成交分别为1,492亿元及2,961亿元。
金融股表现向好，中国平安(601318.SH)、国寿(601628.SH)分别升1%及1.9%。工行(601398.SH)、建行(601939.SH)分别升0.8%及0.5%。招商银行(600036.SH)升1.4%。
纺织服装股逆升，百隆东方(601339.SH)涨停。酷特智能(300840.SZ)、起步股份(603557.SH)分别扬6.2%、6.4%。
光伏、风电股持续下挫，金雷股份(300443.SZ)、双一科技(300690.SZ)、东方电缆(603606.SH)、福莱特(601865.SH)、捷佳伟创(300724.SZ)挫9.2%、8.7%、7.3%、5.8%、5.4%。
特斯拉概念股下滑，新宙邦(300037.SZ)、宁德时代(300750.SZ)、三花智控(002050.SZ)、东山精密(002384.SZ)跌2%-5.7%。
半导体概念股显着回吐，紫光国微(002049.SZ)跌停。北方华创(002371.SZ)、晶瑞股份(300655.SZ)分别挫8%、5.6%。
医疗器械股回升，博晖创新(300318.SZ)、楚天科技(300358.SZ)分别扬8.8%及4.3%。山东药玻(600529.SH)更升近一成。
疫苗股造好，康希诺(688185.SH)涨10.9%。未名医药(002581.SZ)、赛升药业(300485.SZ)、智飞生物(300122.SZ)、复星医药(600196.SH)升1.9%-5.9%。
中潜股份(300526.SZ)复牌跌停。该股因涉嫌信息披露违法违规，遭中证监决定对公司立案调查。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
